Follow the 보로노이 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 보로노이 has recorded 7 insider filings. Market capitalisation: €2,080.7bn. The latest transaction was disclosed on 3 July 2026 (Sale). Among the most active insiders: 김현태. Every trade is openly available.
Analysts rate 보로노이 Buy (bullish), based on 1 analysts. Average price target: ₩450,000.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations
Boronoï is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.